Artificial intelligence healthcare technology company Medopad has just landed $28 million in a Series A funding round with lead investments from China’s NWS Holdings. But the company announced that its goal is to raise $120 million in the next few months.
from MobiHealthNews http://ift.tt/2BZOzzl
February 06, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Health 2.0 and HIMSS: Why coming together strengthens the healthcare communityIndu Subaiya, co-founder of Health 2.0 and executive vice president at HIMSS, discusses the value in bridging the gap between the start-up community and European hospital IT leaders. from MobiHealthNews https://ift.tt/2M4JZW… Read More
How Sitra is fostering healthcare innovation in FinlandPia Heikkurinnen, theme specialist, capacity renewal at Sitra, talks about the support the Finnish government is giving Sitra to back digital health startups and other healthcare innovators. from MobiHealthNews https:… Read More
Care, wellness robotics company Embodied collects $22MPasadena, California-based Embodied announced today it has raised $22 million in Series A funding to support its AI and robotics platforms for improved care and wellness. The investment is led by Calibrate Ventures and Jazz V… Read More
In-Depth: Consumer genomics furthers healthcare foothold but privacy, resource concerns persistIn the last few years consumer genomics has grown in both its offerings and legitimacy. The industry that was once best known for telling clients if they were Italian or Hungarian is now securing its foothold within the healt… Read More
FDA grants DreaMed's de novo request for device-friendly diabetes softwareThe FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. from MobiHealthNews https://ift.tt/2JY1LcV … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment